Hydroxyzine Hydrochloride
- Product NDC
- 50090-6655
- 11-digit product format
- 500906655
- Labeler code
- 50090
- Product ID
- 50090-6655_55f40911-dfa2-4c85-8faa-a0d9ec530be1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Hydroxyzine Hydrochloride
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA040602
- Marketing category
- ANDA
- Marketing start
- 2015-03-31
- Substance
- HYDROXYZINE DIHYDROCHLORIDE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Antihistamine [EPC], Histamine Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Hydroxyzine Hydrochloride
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| HYDROXYZINE DIHYDROCHLORIDE | 25 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 76755771U3 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 995258 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 3d5d3ebf-e57e-4ed1-be97-d4b299fb738d | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 57311cfb-679a-da1a-b70c-8757f7fc431a | Product name | 4 | 20250516 |
| aa1826f4-97c1-4705-bdf0-3bc7d234e618 | Product name | 2 | 20190618 |
| 75cb12ee-8eb2-4f1a-a332-5743a5d0da41 | Product name | 1 | 20151110 |
| 3ca5f78b-43dc-30fe-8014-55b922af52b3 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-6655-0 | Hydroxyzine Hydrochloride | 20 in 1 BOTTLE | TABLET, FILM COATED | 20 | 2 | |
| 50090-6655-1 | Hydroxyzine Hydrochloride | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 2 | |
| 50090-6655-4 | Hydroxyzine Hydrochloride | 60 in 1 BOTTLE | TABLET, FILM COATED | 60 | 2 | |
| 50090-6655-6 | Hydroxyzine Hydrochloride | 15 in 1 BOTTLE | TABLET, FILM COATED | 15 | 2 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-6655-0 | EA - Each | 50090-6655 | a9af4b35-fb43-40d1-8751-5b89c96ff9d2 | 1 | 2023-10-16 |
| 50090-6655-1 | EA - Each | 50090-6655 | 3ec10f19-e824-4d72-bd15-0091df26b892 | 1 | 2023-10-16 |
| 50090-6655-4 | EA - Each | 50090-6655 | d29598ef-cff9-44cd-a84b-38e0fcc0c5c8 | 1 | 2023-10-16 |
| 50090-6655-6 | EA - Each | 50090-6655 | 4bc804da-0656-4335-bd2c-42376abd539b | 1 | 2023-10-16 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-6655 | HYDROXYZINE HYDROCHLORIDE TABLET, FILM COATED [A-S MEDICATION SOLUTIONS] | 2 | Current NDC, 4 package rows | 20230908_3d5d3ebf-e57e-4ed1-be97-d4b299fb738d.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hydroxyzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | Bryant Ranch Prepack | d03fdfd0-5dbd-40fe-a6e3-082a47751c2c | 2025-03-31 | Warnings, Adverse reactions | 040602 ANDA040602 |
| Hydroxyzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | NuCare Pharmaceuticals,Inc. | 79f38cc2-f72f-3f30-e053-2991aa0ac540 | 2024-09-25 | Warnings, Adverse reactions | 040602 ANDA040602 |
| Hydroxyzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | A-S Medication Solutions | c59f24b5-0527-423a-ab14-db1ba1f7763f | 2024-04-16 | Warnings, Adverse reactions | 040602 ANDA040602 |
| Hydroxyzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | Bryant Ranch Prepack | 1c7d31fb-5e3c-456e-be6c-a3baafe60c37 | 2024-04-02 | Warnings, Adverse reactions | 040602 ANDA040602 |
| Hydroxyzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | A-S Medication Solutions | c2bce6a4-9feb-4816-a6d8-151e8ef3314d | 2024-03-11 | Warnings, Adverse reactions | 040602 ANDA040602 |
| Hydroxyzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | A-S Medication Solutions | e83de74d-b2e0-45c5-b072-170a96216d3a | 2024-01-04 | Warnings, Adverse reactions | 040602 ANDA040602 |
| Hydroxyzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | d618157e-f43f-4b31-ba5b-8a13a94885bc | 2023-09-18 | Warnings, Adverse reactions | 040602 ANDA040602 |
| Hydroxyzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | A-S Medication Solutions | 49ee4ecf-b2c0-4301-89da-111e4d853168 | 2023-09-11 | Warnings, Adverse reactions | 040602 ANDA040602 |
| Hydroxyzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | A-S Medication Solutions | 3d5d3ebf-e57e-4ed1-be97-d4b299fb738d | 2023-09-07 | Warnings, Adverse reactions | 040602 ANDA040602 50090-6655 |
| Hydroxyzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | Proficient Rx LP | daefb617-209a-428b-9567-adc5880fa65c | 2022-11-01 | Warnings, Adverse reactions | 040602 ANDA040602 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 995258 | hydrOXYzine HCl 25 MG Oral Tablet | PSN | 3d5d3ebf-e57e-4ed1-be97-d4b299fb738d | 2 |
| 995258 | hydroxyzine hydrochloride 25 MG Oral Tablet | SCD | 3d5d3ebf-e57e-4ed1-be97-d4b299fb738d | 2 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|
| 50090-6655-0 | 50090665500 | 20 TABLET, FILM COATED in 1 BOTTLE (50090-6655-0) | 2023-08-30 | No | No | Current |
| 50090-6655-1 | 50090665501 | 30 TABLET, FILM COATED in 1 BOTTLE (50090-6655-1) | 2023-08-30 | No | No | Current |
| 50090-6655-4 | 50090665504 | 60 TABLET, FILM COATED in 1 BOTTLE (50090-6655-4) | 2023-08-30 | No | No | Current |
| 50090-6655-6 | 50090665506 | 15 TABLET, FILM COATED in 1 BOTTLE (50090-6655-6) | 2023-08-30 | No | No | Current |